Skip to content
10-Q

Quarterly Report

Cogent Biosciences, Inc. COGT

0001193125-25-272334

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 142.38M sh
Shares Diluted Q3 2025 · Sep 30, 2025 137.55M sh
Shares Diluted Q3 2025 · Sep 30, 2025 121.86M sh
Shares Diluted Q3 2025 · Sep 30, 2024 110.17M sh
Shares Diluted Q3 2025 · Sep 30, 2024 101.44M sh
Capex Q3 2025 · Sep 30, 2025 $743K
Capex Q3 2025 · Sep 30, 2024 $498K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$185.34M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$147.21M
Long Term Debt Q3 2025 · Sep 30, 2025 $44.25M
Long Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $125.3M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $98.17M
Stockholders Equity Q3 2025 · Sep 30, 2025 $302.46M
Stockholders Equity Q3 2025 · Jun 30, 2025 $155.04M
Stockholders Equity Q3 2025 · Mar 31, 2025 $219M
Stockholders Equity Q3 2025 · Dec 31, 2024 $256.29M
Stockholders Equity Q3 2025 · Sep 30, 2024 $314.66M
Stockholders Equity Q3 2025 · Jun 30, 2024 $373.22M
Stockholders Equity Q3 2025 · Mar 31, 2024 $422.33M
Stockholders Equity Q3 2025 · Dec 31, 2023 $257.8M
Current Liabilities Q3 2025 · Sep 30, 2025 $62.25M
Current Liabilities Q3 2025 · Dec 31, 2024 $55.71M
Total Liabilities Q3 2025 · Sep 30, 2025 $123.47M
Total Liabilities Q3 2025 · Dec 31, 2024 $71.61M
Current Assets Q3 2025 · Sep 30, 2025 $397.24M
Current Assets Q3 2025 · Dec 31, 2024 $296.47M
Total Assets Q3 2025 · Sep 30, 2025 $425.93M
Total Assets Q3 2025 · Dec 31, 2024 $327.9M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.50
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.55
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$0.52
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$1.44
Eps Basic Q3 2025 · Sep 30, 2025 −$0.50
Eps Basic Q3 2025 · Sep 30, 2025 −$1.55
Eps Basic restated Q3 2025 · Sep 30, 2024 −$0.52
Eps Basic restated Q3 2025 · Sep 30, 2024 −$1.44
Sga Expense Q3 2025 · Sep 30, 2025 $14.37M
Sga Expense Q3 2025 · Sep 30, 2025 $39.65M
Sga Expense Q3 2025 · Sep 30, 2024 $11.8M
Sga Expense Q3 2025 · Sep 30, 2024 $31.59M
Rd Expense Q3 2025 · Sep 30, 2025 $68.99M
Rd Expense Q3 2025 · Sep 30, 2025 $194.22M
Rd Expense Q3 2025 · Sep 30, 2024 $63.61M
Rd Expense Q3 2025 · Sep 30, 2024 $170.61M
Net Income Q3 2025 · Sep 30, 2025 −$80.93M
Net Income Q3 2025 · Sep 30, 2025 −$226.45M
Net Income Q3 2025 · Jun 30, 2025 −$73.53M
Net Income Q3 2025 · Mar 31, 2025 −$71.99M
Net Income Q3 2025 · Sep 30, 2024 −$70.63M
Net Income Q3 2025 · Sep 30, 2024 −$187.93M
Net Income Q3 2025 · Jun 30, 2024 −$58.95M
Net Income Q3 2025 · Mar 31, 2024 −$58.35M
Operating Income Q3 2025 · Sep 30, 2025 −$83.36M
Operating Income Q3 2025 · Sep 30, 2025 −$233.87M
Operating Income Q3 2025 · Sep 30, 2024 −$75.41M
Operating Income Q3 2025 · Sep 30, 2024 −$202.21M